Percutaneous Edge-to-Edge Mitral Valve Repair

Yeo, Khung Keong; Wong, Ningyan

doi:10.4070/kcj.2020.0308

Cited by 6 publications

(6 citation statements)

References 45 publications

(62 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…“G4” features a novel side-dependent grasping and real-time left atrial pressure monitoring. Furthermore, preparation is simplified and steering more precise [ 16 ••, 17 , 18 ].…”

Section: Evolution Of MCmentioning

confidence: 99%

Complications Following MitraClip Implantation

et al. 2021

View full text Add to dashboard Cite

Purpose of Review To provide a detailed overview of complications associated with MitraClip therapy and its development over time with the aim to alert physicians for early recognition of complications and to offer treatment strategies for each complication, if possible. Recent Findings The MitraClip system (MC) is the leading transcatheter technique to treat mitral regurgitation (MR) and has been established as a safe procedure with very low adverse event rates compared to mitral surgery at intermediate to high risk or in secondary MR. Lately, the fourth MC generation has been launched with novel technical features to facilitate device handling, decrease complication rates, and allow the treatment of even complex lesions. Summary Although the complication rate is low, adverse events are associated with increased morbidity and mortality. The most common complications are bleeding, acute kidney failure, procedure-induced mitral stenosis, and an iatrogenic atrial septal defect with unknown clinical impact.

show abstract

“…“G4” features a novel side-dependent grasping and real-time left atrial pressure monitoring. Furthermore, preparation is simplified and steering more precise [ 16 ••, 17 , 18 ].…”

Section: Evolution Of MCmentioning

confidence: 99%

Complications Following MitraClip Implantation

et al. 2021

View full text Add to dashboard Cite

show abstract

“…The following reasons have been proposed for these discordant results [ 11 - 13 ]. First, the definitions of severe MR were different between European and American guidelines.…”

Section: Recent Clinical Trials and Evidence For Teermentioning

confidence: 99%

“…In contrast, patients with an effective regurgitant orifice area of 0.3 to 0.4 cm 2 , but with an LV end-diastolic volume of only 160 to 200 mL, exhibit degrees of MR that are disproportionately higher than would be predicted by LV end-diastolic volume. Thus, these patients were proposed to preferentially benefit from interventions directed at the mitral valve [ 11 - 13 ].…”

Section: Recent Clinical Trials and Evidence For Teermentioning

confidence: 99%

Recent Evidence and Initial Experiences of Transcatheter Edgeto-Edge Repair of the Mitral Valve in South Korea

2021

View full text Add to dashboard Cite

As a percutaneous technique for the reduction of mitral regurgitation, the MitraClip system (Abbott Vascular, Abbott Park, IL, USA) for transcatheter edge-to-edge repair of the mitral valve was developed in 1998 and first used in 2003. Its main advantage is being less invasive than surgery, because it can be performed through a transcatheter approach without any hemodynamic compromise. Recent studies have shown that this procedure reduces symptoms and improves functional capacity with low complication rates. Two randomized clinical trials have investigated the use of this technique for functional mitral regurgitation. The Korean Ministry of Food and Drug Safety approved its use for degenerative mitral regurgitation in 2019, and this procedure started to be performed in Korea in January 2020. Its use for functional mitral regurgitation was also approved in Korea in 2020. In this article, recent evidence on transcatheter edge-to-edge repair of the mitral valve and our initial experiences in Korea will be reviewed.

show abstract

“…Transcatheter edge-to-edge mitral valve repair (TEER), using the MitraClip device for severe mitral regurgitation (MR) was first introduced in 2003. Since then, it has remained the most established percutaneous therapy available for the treatment of severe MR. 1) Current guidelines recommend it is indicated for severe, symptomatic functional MR in patients who continue to have significant symptoms despite optimal guideline-directed medical therapy, as well as in symptomatic patients with severe degenerative MR who are deemed too high risk for conventional surgical therapy in the opinion of the heart team. 2) …”

mentioning

confidence: 99%

Can Multidetector Computed Tomographic Angiography Replace Transesophageal Echocardiography for Preoperative Transcatheter Edge-to-Edge Mitral Valve Repair Planning Purposes?

Park

2023

J Cardiovasc Imaging

View full text Add to dashboard Cite

Percutaneous Edge-to-Edge Mitral Valve Repair

Cited by 6 publications

References 45 publications

Complications Following MitraClip Implantation

Complications Following MitraClip Implantation

Recent Evidence and Initial Experiences of Transcatheter Edgeto-Edge Repair of the Mitral Valve in South Korea

Can Multidetector Computed Tomographic Angiography Replace Transesophageal Echocardiography for Preoperative Transcatheter Edge-to-Edge Mitral Valve Repair Planning Purposes?

Contact Info

Product

Resources

About